AtBioNgn Inc, our mission is to advance the field of cancer treatment by identifying and validating novel anti-cancer targets
We envision a future where our groundbreaking research and targeted treatments redefine cancer care and contribute to a...
The ultimate goal of the BioNgn Inc is to develop targeted therapies that can improve the survival and quality of life for prostate cancer patients. ...
At BioNgn Inc. we are driven by curiosity, passion and one common goal: to develop novel targets for Antineoplastic therapies.
We are a team of young and passionate researchers which is a blend of highly experienced scientists with decades of experiences backed by energetic freshers with keen acumen in
Science
Technology
Artificial Intelligence 
Innovation
As a Start-up, at BioNgn Inc. we initiated R&D activities in Drug Discovery in the Antineoplastic therapeutic area with the help of AI enabled Drug-Design.
The stages involve rigorous research and development across multiple parameters
Our research goes through the following stages:
Continuously pushing the boundaries of science to discover new and effective cancer treatments.
Partnering with leading research institutions and pharmaceutical companies to accelerate the development and delivery of our therapies.
Invest in the latest technologies such as gene editing, and AI-driven drug discovery to enhance research capabilities.
Adhere to ethical guidelines and regulatory standards in all research activities. Ensure transparency and accountability in clinical trials and data reporting.
Encourage a culture of continuous learning and professional development among researchers and staff. Regularly review and improve research methodologies and processes.
Ph.D., M. Sc in Zoology from the University of Kalyani, West Bengal
PhD from Visva Bharati University, India Postdoctoral studies at Institute of Reproductive & Developmental Biology, Imperial College London, UK. Professor in the Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Roorkee, India
Research triangle Institute
University of Pittsburgh
State University of New York at Albany
More than 25 years of experience in R&D and business development in companies like Abbott Laboratories, Aragen Lifescience
M.Sc Chemistry University of Hyderabad
Ph.D. University of Goettingen, Germany
PDF National Taiwan University, Taipei
More than 18 years of experience in Drug Discovery and CRO
Aanshi Sabharwal is a third-year student at the University of Toronto, Mississauga, specializing in Chemistry. She has three years of experience as a Business Development Executive at Pharmaffiliates Inc., where she honed her skills in strategic growth and client relations. Additionally, she has gained hands-on laboratory experience through an internship at Pharmaffiliates India, where she gained expertise in purification of organic compounds and data analysis like NMR interpretation, mass spectroscopy etc. Beyond her academic and professional pursuits, Aanshi is actively engaged in extracurricular activities. She serves as the Director of LeheraKe, a Bollywood dance team recognized by both UTMSU and the Tri-Campus community. Furthermore, she has contributed to science outreach initiatives as a volunteer with the Let's Talk Science UTM team.
Dr. A.K. Sabharwal, an alumnus of the 1971 batch, holds an M.Sc. in Chemistry from IIT Roorkee and a Ph.D. from Bhopal University. With 27 years of industrial experience, he has made significant contributions to analytical research, impurity profiling, and regulatory compliance. In 2001, he transitioned into entrepreneurship, founding Pharmaffiliates, which has since become a global leader in pharmaceutical research and development. Under his leadership, the company has expanded across 90 countries, built a library of 100,000+ compounds, and secured prestigious certifications, including ISO 17034.Dr. Sabharwal's expertise and impact have been recognized with numerous prestigious awards, including the SKOCH Award, CPHI Pharma Awards, and the Golden Business Excellence Award. His commitment to scientific excellence, innovation, and corporate responsibility has significantly influenced the pharmaceutical industry. Additionally, he actively supports education and healthcare initiatives, reinforcing his dedication to societal progress.
